Thetford Corporation
Advised the Dyson-Kissner-Moran Corporation, private investment company, on the sale of Thetford, a global supplier of sanitation, refrigeration and cooking solutions for the Recreational Vehicle and Marine industries
Advised the Dyson-Kissner-Moran Corporation, private investment company, on the sale of Thetford, a global supplier of sanitation, refrigeration and cooking solutions for the Recreational Vehicle and Marine industries
Acted as sole advisor to Paloma Resources, a Houston based, privately held exploration and production company backed by EnCap Investments, on the acquisition of Goodrich Petroleum, a publicly listed (NYSE:GDP) exploration and production company, via a cash tender offer
Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of Bell’s Brewery, a leading US independent craft brewery
Advised MetalX, Inc., a leading ferrous and non-ferrous metal scrap recycling company, on the sale of substantially all of its ferrous scrap processing business to BlueScope Steel Limited, an Australian-listed provider of steel materials, products, systems and technologies
Advised Ambarella, Inc., an AI vision silicon company, on the acquisition of Oculii Corporation, a leading developer of AI software designed to enhance radar perception
Advised EagleClaw Midstream, a leading midstream operator in the Permian Delaware basin, on an all-stock combination with Altus Midstream
Advised Universal Fiber Systems, a leading supplier of solution-dyed fibers, on its $250mm Unitranche Term Loan financing
Advised Intega Group, an ASX-listed testing, inspection and certification buisness operating primarily in Australia and the US, on its strategic review, culminating in a cash sale to Kiwa N.V via scheme of arrangement
Advised MDC Texas Energy in connection with its Chapter 11 bankruptcy and sale of substantially all of its oil and gas assets to Maple Energy Holdings pursuant to a plan of reorganization
Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America